Aetna Inc. (AET) Shares Sold by Chicago Equity Partners LLC
Chicago Equity Partners LLC decreased its stake in shares of Aetna Inc. (NYSE:AET) by 8.9% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 29,590 shares of the company’s stock after selling 2,905 shares during the period. Chicago Equity Partners LLC’s holdings in Aetna were worth $4,493,000 as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in the stock. FTB Advisors Inc. boosted its position in Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC acquired a new position in Aetna during the first quarter valued at $133,000. Liberty Capital Management Inc. boosted its position in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares during the period. Guardian Life Insurance Co. of America boosted its position in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares during the period. Finally, Advisory Services Network LLC acquired a new position in Aetna during the first quarter valued at $195,000. 89.57% of the stock is currently owned by institutional investors.
Aetna Inc. (AET) opened at 158.19 on Friday. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $161.69. The firm has a 50-day moving average price of $155.64 and a 200 day moving average price of $142.91. The company has a market capitalization of $52.53 billion, a P/E ratio of 35.11 and a beta of 0.53.
Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same period last year, the firm posted $2.21 earnings per share. The business’s revenue was down 2.7% on a year-over-year basis. Analysts expect that Aetna Inc. will post $9.54 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This article was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/09/03/aetna-inc-aet-shares-sold-by-chicago-equity-partners-llc.html.
Several equities analysts have weighed in on AET shares. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Argus reiterated a “buy” rating and set a $165.00 price target (up from $145.00) on shares of Aetna in a report on Tuesday, May 30th. Cowen and Company set a $170.00 price target on Aetna and gave the company a “buy” rating in a report on Saturday, May 27th. Credit Suisse Group reiterated a “buy” rating and set a $155.00 price target on shares of Aetna in a report on Wednesday, May 17th. Finally, UBS AG reiterated a “buy” rating and set a $160.00 price target (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Aetna presently has a consensus rating of “Buy” and a consensus target price of $157.99.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.